Medicare Enrolled
Dr. Kathleen Doughney, MD
Hematology · Ormond Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Doughney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Doughney?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Doughney
Dr. Kathleen Doughney is a hematology specialist in Ormond Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Doughney performed 49,990 Medicare services across 2,749 unique beneficiaries.
Between the years covered by Open Payments, Dr. Doughney received a total of $9,020 from 81 pharmaceutical and/or device companies across 526 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Doughney is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 49,990 Medicare services
$9,020 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 50682 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗49,990
Medicare services
Bottom 36% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
2,749
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,631 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 18,870 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 8,200 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 5,590 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 4,260 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 3,540 | $6 | $23 |
| Complete blood count (CBC) with differential | 1,630 | $8 | $29 |
| Blood draw (venipuncture) | 1,565 | $8 | $9 |
| Dexamethasone injection (steroid) | 1,304 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 790 | $1 | $28 |
| Anti-nausea injection (ondansetron/Zofran) | 584 | $0 | $9 |
| Office visit, established patient (30-39 min) | 556 | $94 | $339 |
| Office visit, established patient (20-29 min) | 422 | $63 | $239 |
| Drug injection, under skin or into muscle | 310 | $10 | $69 |
| Administration of chemotherapy into vein, 1 hour or less | 280 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 267 | $16 | $56 |
| Injection of additional new drug or substance into vein | 250 | $11 | $61 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 209 | $48 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 153 | $22 | $84 |
| Hospital follow-up visit, moderate complexity | 134 | $61 | $197 |
| Prothrombin time test (blood clotting) | 118 | $4 | $15 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 107 | $17 | $59 |
| Injection, diphenhydramine hcl, up to 50 mg | 104 | $1 | $3 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 89 | $1 | $6 |
| Administration of chemotherapy into vein, each additional hour | 88 | $22 | $79 |
| Initial hospital admission, high complexity | 87 | $135 | $556 |
| Red blood count, automated test | 61 | $4 | $10 |
| Administration of additional new drug or substance into vein, 1 hour or less | 56 | $49 | $178 |
| Injection of drug or substance into vein | 53 | $26 | $156 |
| New patient office visit (45-59 min) | 53 | $128 | $453 |
| Infusion, normal saline solution , 1000 cc | 53 | $2 | $7 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 43 | $3 | $11 |
| Automated urinalysis | 42 | $2 | $8 |
| Infusion into a vein for hydration, each additional hour | 40 | $9 | $42 |
| Infusion into a vein for hydration, 31-60 minutes | 35 | $24 | $156 |
| Administration of additional new drug or substance into vein using push technique | 27 | $42 | $170 |
| Office visit, established patient, complex (40-54 min) | 20 | $140 | $474 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
39.3% high complexity
51.0% medium
9.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,020
Total received (2018-2024)
Avg $1,289/year across 7 years
Top 46% in FL for hematology
81
Companies
526
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,757 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$263 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,475
2023
$1,651
2022
$1,122
2021
$244
2020
$341
2019
$2,071
2018
$2,115
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,027
Genentech USA, Inc.
$608
Janssen Biotech, Inc.
$608
PFIZER INC.
$514
Celgene Corporation
$444
E.R. Squibb & Sons, L.L.C.
$419
AstraZeneca Pharmaceuticals LP
$313
Merck Sharp & Dohme Corporation
$306
Amgen Inc.
$303
Incyte Corporation
$263
Astellas Pharma US Inc
$219
Foundation Medicine, Inc.
$218
Exelixis Inc.
$215
Daiichi Sankyo Inc.
$186
Gilead Sciences, Inc.
$179
GENZYME CORPORATION
$154
Seagen Inc.
$150
Bayer HealthCare Pharmaceuticals Inc.
$140
Alexion Pharmaceuticals, Inc.
$134
TESARO, Inc.
$129
Lilly USA, LLC
$125
EMD Serono, Inc.
$124
Kite Pharma, Inc.
$112
Ipsen Biopharmaceuticals, Inc
$107
GlaxoSmithKline, LLC.
$105
Pharmacyclics LLC, An AbbVie Company
$105
TerSera Therapeutics LLC
$103
Alnylam Pharmaceuticals Inc.
$100
Takeda Pharmaceuticals U.S.A., Inc.
$100
SANOFI-AVENTIS U.S. LLC
$96
Eisai Inc.
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$69
Clovis Oncology, Inc.
$60
Pharmacosmos Therapeutics Inc.
$58
Merck Sharp & Dohme LLC
$56
Regeneron Healthcare Solutions, Inc.
$51
Seattle Genetics, Inc.
$45
Taiho Oncology, Inc.
$44
JAZZ PHARMACEUTICALS INC.
$42
G1 Therapeutics, Inc.
$40
SECURA BIO, INC.
$40
Novocure Inc.
$40
Karyopharm Therapeutics Inc.
$37
NanoString Technologies, Inc.
$36
Octapharma USA, Inc.
$35
Aurobindo Pharma USA, Inc.
$32
Rigel Pharmaceuticals, Inc.
$32
Pharmacyclics LLC, an AbbVie Company
$30
Puma Biotechnology, Inc.
$29
Lexicon Pharmaceuticals, Inc.
$28
MorphoSys, US Inc.
$26
AbbVie Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$24
Mirati Therapeutics, Inc.
$24
PharmaEssentia USA Corporation
$23
Coherus Biosciences Inc.
$23
Stemline Therapeutics Inc.
$23
AbbVie, Inc.
$22
Otsuka America Pharmaceutical, Inc.
$19
Acrotech Biopharma Inc.
$19
Advanced Accelerator Applications
$19
CTI BioPharma Corp.
$18
SOBI, INC
$17
Janssen Pharmaceuticals, Inc
$17
ImmunoGen, Inc.
$17
Dova Pharmaceuticals
$17
ADC Therapeutics America, Inc.
$17
Array BioPharma Inc.
$16
Agios Pharmaceuticals, Inc.
$15
SERVIER PHARMACEUTICALS LLC
$15
Aadi Bioscience, Inc.
$14
ABBVIE INC.
$14
Aveo Pharmaceuticals, Inc.
$14
ARRAY BIOPHARMA INC
$13
TAIHO ONCOLOGY, INC.
$13
NOVARTIS PHARMACEUTICALS CORPORATION
$13
Teva Pharmaceuticals USA, Inc.
$12
Secura Bio, Inc.
$12
R-Pharm US LLC
$12
Jazz Pharmaceuticals Inc.
$12
Veracyte, Inc.
$4
Top 3 companies account for 24.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Erleada · FARYDAK · FASLODEX · FOTIVDA · FOUNDATIONONE · FYARRO · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · INQOVI · Imbruvica · Inrebic · Ixempra · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONPATTRO · OPDIVO · OPDUALAG · Onivyde · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · Padcev · Perjeta · Polivy · Pomalyst · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vanflyta · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · Yescarta · ZEJULA · Zevalin · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $18 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
8
Per 100K population
1.4
County median income
$66,581
Nearest hospital
ADVENTHEALTH DAYTONA BEACH
6.9 mi
6.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Doughney is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Doughney experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Doughney performed 18,870 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Doughney receive payments from pharmaceutical companies?
Yes. Dr. Doughney received a total of $9,020 from 81 companies across 526 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Doughney's costs compare to other hematologists in Ormond Beach?
Dr. Doughney's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Doughney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Ormond Beach
Browse hematologists in Ormond Beach ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology